&w=600&resize=600,400&ssl=1 "Modi govt’s PLI schemes serving to India make high-value drug as traders see revenue")
Modi govt’s PLI schemes serving to India make high-value drug as traders see revenue
Aurobindo Pharma, Cipla, Dr. Reddy’s Laboratories, Glenmark, and Solar Pharma are among the many high beneficiaries of the schemes, receiving incentives starting from Rs 150 crore to Rs 330 crore learn extra India’s pharmaceutical business is experiencing a major increase below the Modi authorities’s Manufacturing Linked Incentive (PLI) scheme. Excessive worth medicine comparable to biopharmaceuticals,…